Japan’s Kobayashi Pharma yet to find cause of supplement deaths
-
Kobayashi Pharmaceutical President Akihiro Kobayashi, center, apologizes
for the supplement scandal at a news conference on March 29. (Photo by Yo
Inoue) |...
1 hour ago
and high patience!
ReplyDeleteHigh patience?
DeleteHmm ... STI ETF is not highly volatile?
Worry about scooping dead fishes then dive into index investing. You dont see dead fishes yourself. All live swimming fish in the bucket.
ReplyDelete